Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-17-008142
Filing Date
2017-03-17
Accepted
2017-03-17 20:30:31
Documents
2
Period of Report
2017-03-15

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3660
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4591
  Complete submission text file 0000899243-17-008142.txt   9653
Mailing Address 9987 CARVER ROAD CINCINNATI OH 45242
Business Address 9987 CARVER ROAD CINCINNATI OH 45242 (513) 985-1920
Aerpio Pharmaceuticals, Inc. (Issuer) CIK: 0001422142 (see all company filings)

EIN.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 6770 Blank Checks

Mailing Address 88 KEARNY STREET, SUITE 1800 SAN FRANCISCO CA 94108
Business Address
Dalal Anupam (Reporting) CIK: 0001602474 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-53057 | Film No.: 17699880